Major Psychedelics Firm Is Studying Magic Mushrooms To Treat Meth Addiction
Life sciences company Revive Therapeutics Ltd. (OTCQB: RVVTF) is advancing its first Phase I/II clinical trial of oral psilocybin for methamphetamine use disorder treatment while also developing an oral psilocybin thin film strip product.
